Učitavanje...
Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine
BACKGROUND: Sustained pain freedom is an important attribute of acute migraine therapies for patients and physicians. Here we report efficacy of the centrally penetrant, highly selective, 5-HT(1F) agonist lasmiditan on sustained pain freedom and other outcomes at 24 and 48 hours post-dose. STUDY DES...
Spremljeno u:
| Izdano u: | Cephalalgia |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791026/ https://ncbi.nlm.nih.gov/pubmed/31266353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0333102419859313 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|